Your browser doesn't support javascript.
loading
Epidermal growth factor receptor (EGFR) inhibitory monoclonal antibodies and EGFR tyrosine kinase inhibitors have distinct effects on the keratinocyte innate immune response.
Ommori, R; Park, K; Miyagawa, F; Azukizawa, H; Kanno, M; Asada, H.
Affiliation
  • Ommori R; Department of Dermatology, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
  • Park K; Department of Dermatology, Yamato Takada Municipal Hospital, Nara, Japan.
  • Miyagawa F; Department of Dermatology, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
  • Azukizawa H; Department of Dermatology, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
  • Kanno M; Oncology Center, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
  • Asada H; Department of Dermatology, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
Br J Dermatol ; 178(3): 796-797, 2018 03.
Article in En | MEDLINE | ID: mdl-28294296
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Keratinocytes / Protein Kinase Inhibitors / Cetuximab / Panitumumab / Immunity, Innate Limits: Humans Language: En Journal: Br J Dermatol Year: 2018 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Keratinocytes / Protein Kinase Inhibitors / Cetuximab / Panitumumab / Immunity, Innate Limits: Humans Language: En Journal: Br J Dermatol Year: 2018 Type: Article Affiliation country: Japan